|
Volumn 54, Issue 1, 2001, Pages 27-34
|
Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy
|
Author keywords
Aldose reductase; Diabetic neuropathies; Nervous system
|
Indexed keywords
ALDEHYDE REDUCTASE;
ALDOSE REDUCTASE INHIBITOR;
GLUTATHIONE REDUCTASE;
NITRIC OXIDE SYNTHASE;
SORBITOL;
ZENARESTAT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DIABETIC NEUROPATHY;
DOSE RESPONSE;
DRUG DISTRIBUTION;
DRUG TISSUE LEVEL;
DRUG USE;
ENZYME INHIBITION;
ENZYME SPECIFICITY;
KIDNEY CORTEX;
LENS;
MALE;
NONHUMAN;
RAT;
RETINA;
SCIATIC NERVE;
SPINAL CORD;
SPINAL GANGLION;
TISSUE DISTRIBUTION;
|
EID: 0035195531
PISSN: 02724391
EISSN: None
Source Type: Journal
DOI: 10.1002/ddr.1201 Document Type: Article |
Times cited : (6)
|
References (6)
|